Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes.

Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV.

Diabetes Care. 2013 Jan;36(1):63-9. doi: 10.2337/dc12-0759. Epub 2012 Aug 28.

2.

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):72-9. Review.

PMID:
16777545
3.

A systematic review of the cost effectiveness of herpes zoster vaccination.

Szucs TD, Pfeil AM.

Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7. Review.

PMID:
23335045
4.

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M.

Pharmacoeconomics. 2008;26(1):17-32. Review.

PMID:
18088156
5.

Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.

Da Villa G, Sepe A.

Vaccine. 1999 Mar 26;17(13-14):1734-8. Review.

PMID:
10194831
6.

Cost-effectiveness of primary tetanus vaccination among elderly Canadians.

Hutchison BG, Stoddart GL.

CMAJ. 1988 Dec 15;139(12):1143-51. Review.

7.

Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Karnchanasorn R, Ou HY, Lin J, Chuang LM, Chiu KC.

Curr Diab Rep. 2016 Oct;16(10):101. doi: 10.1007/s11892-016-0790-y. Review.

PMID:
27620495

Supplemental Content

Support Center